Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients. [electronic resource]
Producer: 20110420Description: 44-9 p. digitalISSN:- 1651-2057
- Adalimumab
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Dermatologic Agents -- adverse effects
- Etanercept
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Male
- Middle Aged
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.